EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploration of the genomic diversity of third-generation cephalosporin-resistant Escherichia coli in Australian clinical settings

Munazzah Maqbool, Norelle L Sherry, Jason C Kwong, Benjamin P Howden, Claire L Gorrie, Danielle J Ingle, The Controlling Superbugs Study Group

Microbial Genomics · 2026

DOI: 10.1099/mgen.0.001554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2026. Verfasst von Munazzah Maqbool und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia. Hauptthemen laut MEDLINE: Escherichia coli, Escherichia coli Infections. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli resistant to third-generation cephalosporins (3GCs) is a WHO priority pathogen due to its antimicrobial resistance (AMR). In high-income countries, such as Australia, 3GC-resistant E. coli are a common cause of extra-intestinal infections in both healthcare and community settings. Long-term targeted surveillance efforts of AMR in E. coli routinely identify E. coli as a leading pathogen in bacteraemic infections. To date, there has been limited detailed genomic analysis of the drug-resistant E. coli circulating in Australian clinical settings. Here, we sought to explore the genomic diversity of 3GC-resistant isolates (mediated by extended-spectrum beta-lactamase or AmpC), collected from four hospital networks in Melbourne, Australia. We establish the population structure, identifying ten main lineages in addition to multiple other sequence types, demonstrating 3GC resistance has emerged in multiple genetic backgrounds. We show diversity of accessory genome features, including surface antigens, AMR and plasmid profiles. A total of 117 serotypes and 47 capsular loci were detected, with diversity observed within and between main lineages. We identified 17 unique 3GC resistance mechanisms disseminated across the E. coli population, which co-occurred in different combinations of AMR genes and plasmid replicons. We explored the use of genomic clustering as an approach to detect different population dynamics, identifying 99 clusters of which only 15 had more than 5 isolates. This study provides a comprehensive snapshot of these drug-resistant E. coli in Australia over this time period and will serve as a baseline for future studies of clinical and community drug-resistant isolates in Australia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliEscherichia coli InfectionsThird Generation CephalosporinsAustraliaHumansAnti-Bacterial AgentsGenome, BacterialGenetic Variationbeta-LactamasesPlasmidsMicrobial Sensitivity TestsPhylogenyBacterial Proteins

Stichwörter der Autor:innen

Escherichia coliantimicrobial resistancegenomic epidemiologyphylogeneticsthird-generation cephalosporins

Substanzen

Third Generation CephalosporinsAnti-Bacterial Agentsbeta-LactamasesBacterial Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia.
  • Microbiological Diagnostic Unit Public Health Laboratory (MDU-PHL), Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australi…
  • Department of Infectious Diseases & Immunology, Austin Health, Heidelberg, Victoria, Australia.
  • Centre for Pathogen Genomics, The University of Melbourne, Melbourne, Australia.

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Maqbool, M., Sherry, N. L., Kwong, J. C., Howden, B. P., Gorrie, C. L., Ingle, D. J., & The Controlling Superbugs Study Group (2026). Exploration of the genomic diversity of third-generation cephalosporin-resistant Escherichia coli in Australian clinical settings. Microbial Genomics. https://doi.org/10.1099/mgen.0.001554

Vancouver

Maqbool M, Sherry NL, Kwong JC, Howden BP, Gorrie CL, Ingle DJ, et al. Exploration of the genomic diversity of third-generation cephalosporin-resistant Escherichia coli in Australian clinical settings. Microbial Genomics. 2026. doi:10.1099/mgen.0.001554

BibTeX
@article{Maqbool2026,
  author = {Maqbool, Munazzah and Sherry, Norelle L and Kwong, Jason C and Howden, Benjamin P and Gorrie, Claire L and Ingle, Danielle J and The Controlling Superbugs Study Group},
  title = {Exploration of the genomic diversity of third-generation cephalosporin-resistant Escherichia coli in Australian clinical settings},
  journal = {Microbial Genomics},
  year = {2026},
  doi = {10.1099/mgen.0.001554}
}
Kostenlos starten →